molybdenum has been researched along with Coronary Restenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baklanov, D; de Muinck, ED; Lindner, V; Maciag, T; Mandinov, L; Mandinova, A; Moodie, KL; Redican, F; Simons, M; Zhuang, Z | 1 |
| Aoki, J; Hara, K; Higashikuni, Y; Nakajima, H; Nakazawa, G; Ohtsuki, S; Onuma, Y; Tanabe, K; Yachi, S; Yagishita, A; Yamamoto, H | 1 |
1 trial(s) available for molybdenum and Coronary Restenosis
| Article | Year |
|---|---|
Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy.
Topics: Aged; Angioplasty, Balloon, Coronary; Chromates; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Hypersensitivity; Immunosuppressive Agents; Male; Manganese; Metals; Middle Aged; Molybdenum; Nickel; Patch Tests; Sirolimus; Titanium; Treatment Outcome; Tunica Intima | 2008 |
1 other study(ies) available for molybdenum and Coronary Restenosis
| Article | Year |
|---|---|
Inhibition of in-stent restenosis by oral copper chelation in porcine coronary arteries.
Topics: Animals; Ceruloplasmin; Chelating Agents; Chelation Therapy; Copper; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Male; Molybdenum; Stents; Swine; Time Factors; Tunica Intima; Ultrasonography, Interventional | 2006 |